American Journal of Neuroradiology 25:819-826, May 2004
© 2004 American Society of Neuroradiology
INTERVENTIONAL
Preliminary Experience with Intra-Arterial Nicardipine as a Treatment for Cerebral Vasospasm
a Department of Neurology, Massachusetts General Hospital, Boston
b Department of Interventional Neuroradiology, Massachusetts General Hospital, Boston
c Department of Neurosurgery, Massachusetts General Hospital, Boston
Address reprint requests to Neeraj Badjatia, MD, Neurocritical Care Service, Blake 1291, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114
BACKGROUND AND PURPOSE: Papaverine is the primary intra-arterial (IA) treatment for vasospasm after aneurysmal subarachnoid hemorrhage (SAH); however, is it limited in effect and by adverse effects. We prospectively studied the use of IA nicardipine as a treatment for vasospasm.
METHODS: Over 12 months, all patients with SAH who required interventional treatment for vasospasm were given IA nicardipine with or without angioplasty. Vasospasm was determined by serial clinical assessments and/or daily transcranial Doppler (TCD) imaging and confirmed by angiography. Doses of IA nicardipine per vessel were 0.5–6 mg. All patients were monitored for increased intracranial pressure (ICP) and change in cardiovascular or neurologic status.
RESULTS: Forty-four vessels in 18 patients with vasospasm were treated with IA nicardipine alone. TCD data for 38 vessels (15 cases) were available. All vessels demonstrated immediate angiographic dilatation after IA nicardipine. No sustained cardiovascular changes were after treatment. ICP was transiently elevated in five patients and persistently elevated in one. Mean peak systolic velocities at TCD imaging were significantly reduced from pretreatment values in all treated vessels for 4 days after infusion (268.9 ± 77.8 vs 197.6 ± 74.1 cm/s, P < .001). Neurologic improvement after IA nicardipine occurred in eight (42.1%) patients. No clinical deterioration was noted.
CONCLUSION: As shown by TCD imaging, IA nicardipine has an immediate and sustained effect on vasospasm. It does not appear to have sustained effect on ICP or cardiovascular status. This treatment warrants further study to determine its safety and efficacy.
This article has been cited by other articles:
 |
|
 |
|
  W.E. Zink, C.P. Foley, J.P. Dyke, M.J. Synan, A.L. Chakrapani, D.J. Ballon, W.L. Olbricht, and Y.P. Gobin Novel Microcatheters for Selective Intra-Arterial Injection of Fluid in the Rat Brain AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1190 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, March 1, 2009; 40(3): 994 - 1025. [Full Text] [PDF]
|
|
|
|
|
|
R.G. Nogueira, M.H. Lev, L. Roccatagliata, J.A. Hirsch, R.G. Gonzalez, C.S. Ogilvy, E.F. Halpern, G.A. Rordorf, J.D. Rabinov, and J.C. Pryor Intra-Arterial Nicardipine Infusion Improves CT Perfusion-Measured Cerebral Blood Flow in Patients with Subarachnoid Hemorrhage-Induced Vasospasm AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): 160 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hanggi, B. Turowski, K. Beseoglu, M. Yong, and H.J. Steiger Intra-Arterial Nimodipine for Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Influence on Clinical Course and Cerebral Perfusion AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zwienenberg-Lee, J. Hartman, N. Rudisill, L. K. Madden, K. Smith, J. Eskridge, D. Newell, B. Verweij, M. R. Bullock, A. Baker, et al. Effect of Prophylactic Transluminal Balloon Angioplasty on Cerebral Vasospasm and Outcome in Patients With Fisher Grade III Subarachnoid Hemorrhage: Results of a Phase II Multicenter, Randomized, Clinical Trial Stroke, June 1, 2008; 39(6): 1759 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Fraticelli, B. P. Cholley, M.-R. Losser, J.-P. Saint Maurice, and D. Payen Milrinone for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage Stroke, March 1, 2008; 39(3): 893 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Varma, K. Price, V. Jayakrishnan, B. Manickam, and G. Kessell Anaesthetic considerations for interventional neuroradiology Br. J. Anaesth., July 1, 2007; 99(1): 75 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G. Tejada, R.A. Taylor, M.S. Ugurel, M. Hayakawa, S.K. Lee, and J.C. Chaloupka Safety and Feasibility of Intra-Arterial Nicardipine for the Treatment of Subarachnoid Hemorrhage-Associated Vasospasm: Initial Clinical Experience with High-Dose Infusions AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 844 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Barth, H.-H. Capelle, S. Weidauer, C. Weiss, E. Munch, C. Thome, T. Luecke, P. Schmiedek, H. Kasuya, and P. Vajkoczy Effect of Nicardipine Prolonged-Release Implants on Cerebral Vasospasm and Clinical Outcome After Severe Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Double-Blind Phase IIa Study Stroke, February 1, 2007; 38(2): 330 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Singhal, M. A. Topcuoglu, D. J. Dorer, C. S. Ogilvy, B. S. Carter, and W. J. Koroshetz SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage Neurology, March 22, 2005; 64(6): 1008 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pelz, T. Andersson, P. Lylyk, M. Negoro, and M. Soderman Stroke Review: Advances in Interventional Neuroradiology 2004 Stroke, February 1, 2005; 36(2): 211 - 214. [Full Text] [PDF]
|
|